Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
small nucleolar RNA, C/D box 50B |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
golgin A6 family like 7 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||||
|
fatty acid amide hydrolase pseudogene 1 |
|
phenotype | 0.300 | limited | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||||
|
MAP7 domain containing 3 | 4.6E-10 |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||||
|
podocan like 1 | 4.4E-13 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
pleckstrin homology domain containing S1 | 2.1E-22 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||||
|
pleckstrin homology domain containing S1 | 2.1E-22 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||||
|
pleckstrin homology domain containing S1 | 2.1E-22 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||||
|
haloacid dehalogenase like hydrolase domain containing 2 | 3.9E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
MON1 homolog A, secretory trafficking associated | 2.3E-09 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||||
|
keratin 87 pseudogene |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
defective in cullin neddylation 1 domain containing 3 | 0.87 |
|
group | 0.300 | None | 0 | 0 | |||||||||||||
|
human papillomavirus (type 18) integration site 1 |
|
phenotype | 0.300 | None | 0 | 0 | ||||||||||||||
|
olfactory receptor family 5 subfamily M member 1 | 1.9E-03 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||||
|
NADH:ubiquinone oxidoreductase subunit S5 | 2.6E-02 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.600 | None | 1.000 | 15 | 0 | 2001 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.600 | None | 1.000 | 11 | 0 | 1995 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 1.000 | 11 | 0 | 1995 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 1.000 | 11 | 0 | 1995 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 1.000 | 11 | 0 | 1995 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.320 | None | 1.000 | 11 | 0 | 1995 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.330 | None | 1.000 | 11 | 0 | 1995 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.400 | None | 1.000 | 11 | 0 | 1995 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 1.000 | 10 | 0 | 2000 | 2014 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 1.000 | 9 | 0 | 1995 | 2012 |